PNPT1-induced mitochondrial dysfunction drives osteoclast activation via post-transcriptional Nrf2 suppression and lipid peroxidation signaling
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.117174 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Chengyan Liu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Osteoclasts, Mitochondria, NF-E2-Related Factor 2, Osteoporosis. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Shanxi Province Natural Science Foundation, National Natural Science Foundation of China, Shanghai Municipal Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND: Polynucleotide phosphorylase 1 (PNPT1) functions as a crucial mitochondrial enzyme; nevertheless, its potential genetic correlation with osteoporosis and its specific regulatory impact on osteoclastogenesis remain to be elucidated. METHODS: We executed a two-sample Mendelian randomization (MR) strategy to interrogate the causal link connecting PNPT1 expression to osteoporosis risk. For in vivo substantiation, we utilized both an ovariectomized (OVX) murine model and an adeno-associated virus (AAV)-driven overexpression system. Extensive in vitro assays employing RANKL-stimulated RAW264.7 macrophages were conducted to evaluate osteoclast differentiation, mitochondrial dynamics, autophagic flux, and intracellular oxidative stress through molecular and morphological analyses. RESULTS: MR evaluations pinpointed genetically predicted elevated PNPT1 expression as a potential genetic risk factor for osteoporosis. In vivo observations revealed a significant surge of PNPT1 within the osteoclast precursors of OVX subjects. In vitro, the ectopic overexpression of PNPT1 significantly enhanced osteoclastogenesis and bone degradation while simultaneously triggering severe mitochondrial depolarization alongside the accumulation of reactive oxygen species (ROS). On the contrary, targeted Pnpt1 silencing markedly suppressed osteoclast maturation. Mechanistic probes demonstrated that PNPT1 disrupted autophagic flux, marked by p62 accumulation. Notably, even with a compensatory transcriptional rise in Nrf2 mRNA, PNPT1 overexpression provoked a marked downregulation of Nrf2 and xCT proteins, suggesting a potent post-transcriptional suppression of the cellular antioxidant shield. This uncoupling invariably precipitated sub-lethal lipid peroxidation that amplifies osteoclastogenic signaling. Concordantly, AAV-mediated systemic PNPT1 amplification aggravated trabecular bone deterioration in vivo. CONCLUSION: Guided by our MR findings and validated through our functional models, PNPT1 emerges as a potential genetic risk factor for osteoporosis. By inciting mitochondrial damage, provoking ROS buildup, and decoupling the protective autophagy-Nrf2/xCT axis, PNPT1 promotes osteoclastogenesis, thereby introducing a promising immunopharmacological target for restraining pathological bone resorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bone and Joint Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- Department of Bone and Joint Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: kongning@xjtu.edu.cn.
- Department of Bone and Joint Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: yangpei@xjtu.edu.cn.
Förderung
- Shanxi Province Natural Science Foundation
- National Natural Science Foundation of China
- Shanghai Municipal Natural Science Foundation
Zitieren
APA
Liu, C., Nie, X., Xing, F., Wang, D., Liu, C., Lu, F., Zhang, J., Zhao, Y., Cao, R., Luo, S., Liu, Z., Chen, Y., Dong, G., Han, C., Zhao, X., Li, Y., Tian, R., Wang, K., Kong, N., & Yang, P. (2026). PNPT1-induced mitochondrial dysfunction drives osteoclast activation via post-transcriptional Nrf2 suppression and lipid peroxidation signaling. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117174
Vancouver
Liu C, Nie X, Xing F, Wang D, Liu C, Lu F, et al. PNPT1-induced mitochondrial dysfunction drives osteoclast activation via post-transcriptional Nrf2 suppression and lipid peroxidation signaling. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117174
BibTeX
@article{Liu2026,
author = {Liu, Chengyan and Nie, Xinlin and Xing, Fangze and Wang, Dongbo and Liu, Chenkun and Lu, Feng and Zhang, Jiewen and Zhao, Yiwei and Cao, Ruomu and Luo, Sen and Liu, Zeyu and Chen, Yang and Dong, Gongming and Han, Chang and Zhao, Xing and Li, Yiyang and Tian, Run and Wang, Kunzheng and Kong, Ning and Yang, Pei},
title = {PNPT1-induced mitochondrial dysfunction drives osteoclast activation via post-transcriptional Nrf2 suppression and lipid peroxidation signaling},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.117174}
}
EUVIMED